Intravenous immunoglobulin (IVIG), primarily containing over 95% IgG and minute amounts of IgM or IgA derived from human plasma, may potentially offer clinical benefits in preventing or treating viral infections (21). The gene discussed is CD79A; the disease is viral infectious disease.